All stock lists
SCHOTT Pharma AG & Co. KGaA (XETRA:1SXP.DE)
Germany · Delayed Price · Currency is EUR
Healthcare · Medical Instruments & Supplies
25.50-0.20 (-0.78%)
Insider Score
––Not scored
1SXP.DE Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
1SXP.DE Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 281.76 M | 247.88 M | 240.19 M | 247.58 M | 256.18 M | — |
| Revenue Growth (YoY) | 9.99 % | — | — | — | — | — |
| Cost of Revenue | 195.38 M | 172.78 M | 160.44 M | 171.50 M | 160.23 M | — |
| Gross Profit | 86.38 M | 75.10 M | 79.75 M | 76.08 M | 95.95 M | — |
| SG&A Expense | 35.30 M | 32.51 M | 33.73 M | 32.14 M | 32.24 M | — |
| R&D Expense | 6.34 M | 6.05 M | 7.34 M | 6.36 M | 7.33 M | — |
| Operating Expenses | 37.48 M | 35.55 M | 40.70 M | 34.71 M | 35.98 M | — |
| Operating Income | 48.90 M | 39.55 M | 39.05 M | 41.37 M | 59.97 M | — |
| Pretax Income | 51.23 M | 40.31 M | 42.04 M | 41.77 M | 59.99 M | — |
| Tax Provision | 12.25 M | 9.17 M | 8.76 M | 8.09 M | 14.40 M | — |
| Net Income | 38.83 M | 31.01 M | 33.18 M | 33.55 M | 45.43 M | — |
| EPS (Basic) | 0.26 | 0.21 | 0.22 | — | 0.30 | 0.25 |
| EPS (Diluted) | 0.26 | 0.21 | 0.22 | — | 0.30 | 0.25 |
| Shares Outstanding | 149.34 M | 147.68 M | 150.82 M | — | 151.43 M | 152.55 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.